251 related articles for article (PubMed ID: 23506213)
1. A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients.
Pan X; Li Y; Feng J; Wang X; Hao B; Shi R; Zhang G
BMC Cancer; 2013 Mar; 13():126. PubMed ID: 23506213
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and MDM2 SNP309 association with gastric cancer susceptibility.
Moradi MT; Salehi Z; Asl SF; Aminian K; Hashtchin AR
Genet Test Mol Biomarkers; 2013 Nov; 17(11):794-8. PubMed ID: 24010568
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Helicobacter pylori with genetic variants in the MDM2 promoter, is associated with gastric cancer susceptibility in Chinese patients.
Wang X; Yang J; Ho B; Yang Y; Huang Z; Zhang Z; Zhang G
Helicobacter; 2009 Oct; 14(5):114-9. PubMed ID: 19751436
[TBL] [Abstract][Full Text] [Related]
4. MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.
Ohmiya N; Taguchi A; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H
J Clin Oncol; 2006 Sep; 24(27):4434-40. PubMed ID: 16983111
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.
Ortiz GJ; Li Y; Post SM; Pant V; Xiong S; Larsson CA; El-Naggar AK; Johnson DG; Lozano G
Oncogene; 2018 Jan; 37(3):332-340. PubMed ID: 28925402
[TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphism of MDM2 SNP309 in Patients with Helicobacter Pylori-Associated Gastritis.
Tongtawee T; Dechsukhum C; Leeanansaksiri W; Kaewpitoon S; Kaewpitoon N; Loyd RA; Matrakool L; Panpimanmas S
Asian Pac J Cancer Prev; 2015; 16(16):7049-52. PubMed ID: 26514489
[TBL] [Abstract][Full Text] [Related]
7. Association of the
Miedl H; Lebhard J; Ehart L; Schreiber M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691044
[TBL] [Abstract][Full Text] [Related]
8. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: meta-analysis of 15 studies.
Shen W; Hu P; Cao JQ; Liu XX; Shao JH
J Int Med Res; 2014 Oct; 42(5):1065-76. PubMed ID: 25070969
[TBL] [Abstract][Full Text] [Related]
9. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
10. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population.
Ma H; Hu Z; Zhai X; Wang S; Wang X; Qin J; Jin G; Liu J; Wang X; Wei Q; Shen H
Cancer Lett; 2006 Aug; 240(2):261-7. PubMed ID: 16288830
[TBL] [Abstract][Full Text] [Related]
12. Association between SNP309 and del1518 Polymorphism in MDM2 Homologue and Esophageal Squamous Cell Carcinoma Risk in Chinese Population of Shandong Province.
Zhang L; Zhu Z; Wu H; Wang K
Ann Clin Lab Sci; 2015; 45(4):433-7. PubMed ID: 26275695
[TBL] [Abstract][Full Text] [Related]
13. MDM2 SNP309T>G polymorphism increases susceptibility to hepatitis B virus-related hepatocellular carcinoma in a northeast Han Chinese population.
Wang X; Zhang X; Qiu B; Tang Y; Sun H; Ji H; Liu Y; Shi L; Song G; Yang Y
Liver Int; 2012 Aug; 32(7):1172-8. PubMed ID: 22413855
[TBL] [Abstract][Full Text] [Related]
14. MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.
Liu YC; Hsiao HH; Yang WC; Liu TC; Chang CS; Yang MY; Lin PM; Hsu JF; Lee CP; Lin SF
Mol Carcinog; 2014 Dec; 53(12):951-9. PubMed ID: 23818300
[TBL] [Abstract][Full Text] [Related]
15. No association of MDM2 T309G polymorphism with susceptibility to Korean gastric cancer patients.
Cho YG; Choi BJ; Song JH; Kim CJ; Cao Z; Nam SW; Lee JY; Park WS
Neoplasma; 2008; 55(3):256-60. PubMed ID: 18348658
[TBL] [Abstract][Full Text] [Related]
16. MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.
Zhou G; Zhai Y; Cui Y; Zhang X; Dong X; Yang H; He Y; Yao K; Zhang H; Zhi L; Yuan X; Qiu W; Zhang X; Shen Y; Qiang B; He F
Clin Cancer Res; 2007 May; 13(9):2627-33. PubMed ID: 17473193
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.
Xiao FK; Guo S; Yang F; Zhao LS; Wang LD
J Gene Med; 2019 May; 21(5):e3086. PubMed ID: 30861607
[TBL] [Abstract][Full Text] [Related]
18. MDM2 SNP309 polymorphism is associated with colorectal cancer risk.
Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M
Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837
[TBL] [Abstract][Full Text] [Related]
19. TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.
Wang X; Xue L; Yang Y; Xu L; Zhang G
PLoS One; 2013; 8(6):e65731. PubMed ID: 23776537
[TBL] [Abstract][Full Text] [Related]
20. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
